New Delhi, India – 110 016

Ronapreve (Casirivimab Imdevimab) available Delhi, Mumbai, Madras, Hyderabad, Bangalore India

Ronapreve (Casirivimab Imdevimab) Injection

Generic brands for Casirivimab Imdevimab Tablets Available in India

Brand Name Ronapreve
Generic Name Casirivimab Imdevimab
Strength 120mg
Manufacturer CIPLA LTD

 

Description

Description

Ronapreve 120mg Injection contains the active constituent Casirivimab + Imdevimab, a type of protein called monoclonal antibodies. It is used to treat patients with confirmed acute COVID-19 infection. It is also indicated to prevent acute COVID-19 infection. Acute covid-19 infection is caused by a virus called coronavirus. People can get COVID-19 through contact with another person who has the virus.

Do not take Ronapreve 120mg Injection if you are allergic to Casirivimab + Imdevimab or any other ingredients. This medicine can cause allergic reactions following the infusion or injection; notify your physician immediately if you face any of the infusion reactions. Before you take this injection, inform your doctor if you have been vaccinated against COVID infection. Inform your doctor if you are pregnant or breastfeeding before initiating the treatment.

The side effects of this  Ronapreve 120mg Injection monoclonal antibody therapy are injection site reactions, fever, flushing, shortness of breath, chest tightness, nausea, and vomiting. If you experience any of these side effects, immediately inform your doctor. This medicine is recommended to use in individuals aged 12 years and older and weighing at least 35.5kg.

Date of Approval

Casirivimab + Imdevimab is an antiviral drug that belongs to the class of medications called monoclonal antibodies. FDA approved it on November 21, 2020, for treating acute COVID-19 infection.

Mechanism of Action of Casirivimab Imdevimab

Casirivimab + Imdevimab are two recombinant human monoclonal antibodies that attach to a protein on the surface of the coronavirus called the ‘spike protein.’ This stops the virus from getting into your cells and causing an infection. They block the receptor binding domain (RBD) to the ACE2 receptor and prevent viral attachment to host cells. This can help your body to overcome the virus infection and may help you get better faster.

Uses of Casirivimab Imdevimab

Casirivimab + Imdevimab is available as an injection. It is used to treat patients with confirmed acute COVID-19 infection. It is also indicated to prevent acute COVID-19 infection. Acute covid-19 infection is caused by a virus called coronavirus. People can get COVID-19 through contact with another person who has the virus.

Casirivimab Imdevimab Dosage available

Casirivimab + Imdevimab is given as an infusion into your vein that lasts for 20 to 30 minutes, or it can be given as a subcutaneous (under the skin) injection. This injection will be given to you by a doctor or nurse who is experienced in the use of this type of treatment. They will monitor you closely while you are being given this medicine. Do not self-administer this medicine.

 

We can ship to :

FAQ's

NEWS / UPDATES

References

  1. Ronapreve 120 mg/mL solution for injection or infusion – Summary of Product Characteristics (SmPC) – (emc). www.medicines.org.uk. Published January 2023. Accessed May 22, 2023. https://www.medicines.org.uk/emc/product/12863/smpc
  2. fact sheet for health care providers emergency use authorization (eua) of regen-cov tm (Casirivimab with Imdevimab); (Revised January 2022.) Accessed May 22, 2023 https://www.fda.gov/media/145611/download
  3. Paroma Deb et al; An update to the monoclonal antibody as a therapeutic option against COVID-19, [Published on Apr 2021], [Accessed May 22, 2023] https://www.sciencedirect.com/science/article/pii/S2590053621000197
  4. John P Manis; Overview of therapeutic monoclonal antibodies, [Published on May 2021], [Accessed May 22, 2023], https://www.uptodate.com/contents/overview-of-therapeutic-monoclonal-antibodies#H395449287
Categories , , , Tag

Related products

Frequently Asked Questions

South Delhi Pharma is a consultancy company which facilitates patients, hospitals, clinicians and researchers in accessing products which are not available or approved in their home country. IPN also helps companies in designing and implementing PAP (Patient Assistance Plan) or Patient Centric Programs, CROs in accessing products for clinical trials. More Details

South Delhi Pharma 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India) Email: [email protected]

There are several ways through which we can be contacted. Mobile: We can be reached on +91-9891296838 ( 9am – 6pm IST, on working days) Email: Please send your enquires directly to [email protected]. We will respond within 1 working days after receiving your mail. Please mention your detail enquiry & contact details with ISD code in your email. For otherwise urgent requirement, we can be reached through email [email protected] during closing hours. We will respond within 2 hours provided you submit your detailed enquiry & contact number with ISD Code.

Website: You can visit our website and fill in enquiry form mentioned on the website. We will respond within 1 working days after receiving your query form. Office: You can visit our office during working hours if you are in Delhi NCR. South Delhi Pharma 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India).

Images shown on website are sometimes taken from image released by manufacturing company specific to country/Region. Over period of time they go through some minor makeover depending on regulatory changes, country specific, language specific or batch variations. This sometime not possible to cover all variations on website. However, we assure genuine sourcing for all our products which are supplied using The Indian Pharma services

Medicines once shipped will not be taken back. We will assist you with the Export Invoice and tracking details of your order. International orders might be subject to import taxes/duties. For information, please contact your local customs authority. Any such taxes are the responsibility of the parcel recipient and are not paid by us.

There are some medicines which have been approved recently in USA or Europe but not yet approved in India or any other countries are not permitted to be imported or marketed commercially. However, they may be required for the treatment of patients to save their lives who have exhausted all other available treatment options in their country. Named – Patient Program is to facilitate import of such medicines for personal use. There is a provision under the Indian Drugs and Cosmetics Rules, 1945, that permits the patient to import these medicine in small quantity. Similar regulatory provision also exist in other countries. We assist patient in preparing legal documents for import and connecting them with authorized suppliers in USA and Europe to secure genuine products.

A generic drug is a drug defined as “a drug product that is comparable to a brand/reference listed drug product in dosage form, strength, quality and performance characteristics, and intended use”. There are Indian companies which manufacture and market these generic medicines after getting approval from Regulatory Authority of the country. These generic medicines contain the same active ingredients as the original formulation and are identical or within an acceptable bioequivalent range to the Innovator drug counterpart with respect to pharmacokinetic and pharmaco-dynamic properties. By extension, therefore, generics are considered identical in dose, strength, route of administration, safety, efficacy, and intended use. They are labeled with the name of the manufacturer and the adopted name (nonproprietary name) of the drug. When generic products become available, the market competition often leads to substantially lower prices and thereby make is affordable for large number of needy patients.

It usually takes 8-9 working days after dispatch to reach medicine at outside India locations. Additional delays may occur due to heavy load on postal services and customs.

We advise to transfer money only through Interbank Transfer Modalities;

  • Online Net-banking for within India transfer.
  • International Wire Transfer (SWIFT) from outside India.
  • Cash on Delivery within India.

Cash on Delivery (COD) option is only available if the medicine is purchased and delivered in India. Preferred locations within India for COD facilities are within Municipal limits of New Delhi & NCR, Mumbai, Bangalore, Kolkata, Chennai & Hyderabad

Customer Reviews

“A review from a customer who benefited from your product. Reviews can be a highly effective way of establishing credibility and increasing your company's reputation.”
Customer Name
“A review from a customer who benefited from your product. Reviews can be a highly effective way of establishing credibility and increasing your company's reputation.”
Customer Name
“A review from a customer who benefited from your product. Reviews can be a highly effective way of establishing credibility and increasing your company's reputation.”
Customer Name